CBS 2019
CBSMD教育中心
English

动脉粥样硬化性心血管疾病

科研文章

荐读文献

Effect of the PCSK9 Inhibitor Evolocumab on Total Cardiovascular Events in Patients With Cardiovascular DiseaseA Prespecified Analysis From the FOURIER Trial High-Risk Coronary Plaque Regression After Intensive Lifestyle Intervention in Nonbstructive Coronary Disease: A Randomized Study Haptoglobin genotype: a determinant of cardiovascular complication risk in type 1 diabetes Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Association of White Matter Hyperintensities and Cardiovascular Disease: The Importance of Microcirculatory Disease The contribution of tissue-grouped BMI-associated gene sets to cardiometabolic-disease risk: a Mendelian randomization study Myocardial bridging of the left anterior descending coronary artery is associated with reduced myocardial perfusion reserve: a 13N-ammonia PET study Coronary calcium as a predictor of coronary events in four racial or ethnic groups Association of Coronary Artery Calcium With Long-term, Cause-Specific Mortality Among Young Adults

Review ArticleApril 15, 2020

JOURNAL: Article Link

The Science Underlying COVID-19: Implications for the Cardiovascular System

PP Liu, A Blet, D Smyth et al. Keywords: COVID-19; pre-existing cardiovascular disease; ACE2 receptor; organ dysfunction;

Full Text PDF